Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego
California
92121
U.S.A.
Phone:
858-794-8889
Fax:
858-259-2539
|
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the dispersion and absorption of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.
Email:
hr@halozyme.com
Ownership:
Public
Web Site:
Halozyme Therapeutics, Inc.
Employees:
152
Symbol: HALO
|